Contribution: Industrial Research Assistance Program – Contributions to Firms
Acasti Pharma Inc
$326,357.00
Development of the manufacturing and encapsulation process for CaPre
FY 2019-20 · 2019-07-01
Summary
The project involves the commercial scale-up of certain components of the CaPre manufacturing process and aims to achieve a level of production capable of meeting the expected demand at the time of commercialization.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Laval|Laval, Quebec, Canada
Recipient Type
For-profit organization
Business Number
864885652
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2019-07-01 | 2019-20 | $750,000.00 |
| 2 | 2019-07-01 | 2019-20 | $326,357.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by -203 days. The total amended value is -423,643 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de -203 jours. La valeur totale des modifications est de - 423 643 dollars.
Agreement End Date
2020-08-28
Agreement Number
933064
Agreement Start Date
2019-07-01
Agreement Title
Development of the manufacturing and encapsulation process for CaPre
Agreement Title (French)
Développement du procédé de fabrication et d’encapsulation du CaPre
Agreement Type
Contribution
Agreement Value
$326,357.00
Amendment Date
2020-10-29
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The project involves the commercial scale-up of certain components of the CaPre manufacturing process and aims to achieve a level of production capable of meeting the expected demand at the time of commercialization.
Description (French)
Le projet consiste à la mise à l’échelle commerciale de certaines composantes du procédé de fabrication du CaPre et vise à atteindre un niveau de production capable de répondre à la demande prévue au moment de la commercialisation.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vimy
Federal Riding (French)
Vimy
Federal Riding Number
24078
NAICS Code
325410
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
864885652
Recipient City
Laval|Laval
Recipient Country
CA
Recipient Legal Name
Acasti Pharma Inc
Recipient Postal Code
H7T 0A3
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2019-2020-Q2-933064
